These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 135588

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mafenide (Sulfamylon) inhibits plasmin fibrinolytic activity.
    Weisdorf DJ, Aldridge JH.
    Thromb Haemost; 1988 Jun 16; 59(3):440-4. PubMed ID: 2973151
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Staphylokinase reduces plasmin formation by endogenous plasminogen activators.
    Jin T, Bokarewa M, Zhu Y, Tarkowski A.
    Eur J Haematol; 2008 Jul 16; 81(1):8-17. PubMed ID: 18331597
    [Abstract] [Full Text] [Related]

  • 8. Extrinsic plasminogen activator: a new principle in fibrinolysis.
    Lijnen HR.
    Behring Inst Mitt; 1983 Aug 16; (73):43-55. PubMed ID: 6236789
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Methods for studying fibrinolytic pathway components in human plasma.
    Wohl RC, Sinio L, Robbins KC.
    Thromb Res; 1982 Sep 01; 27(5):523-35. PubMed ID: 6217585
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P, Kant KS, Allen C, Pollak VE.
    J Lab Clin Med; 1984 Dec 01; 104(6):962-76. PubMed ID: 6239000
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo.
    Suelves M, López-Alemany R, Lluís F, Aniorte G, Serrano E, Parra M, Carmeliet P, Muñoz-Cánoves P.
    Blood; 2002 Apr 15; 99(8):2835-44. PubMed ID: 11929773
    [Abstract] [Full Text] [Related]

  • 17. The enhancement of chloroform-induced plasma proteolytic activity by epsilon aminocaproic acid.
    DONALDSON VH, RATNOFF OD.
    J Exp Med; 1962 Apr 01; 115(4):695-706. PubMed ID: 13887179
    [Abstract] [Full Text] [Related]

  • 18. [The effect of heparin on the proteolytic and fibrinolytic activity on plasmin(ogen) and fibrin clot lysis].
    Kudinov SA, Kolesnik LA, Makogonenko EM, Shuliakovskaia TA.
    Biokhimiia; 1989 Nov 01; 54(11):1881-7. PubMed ID: 2534055
    [Abstract] [Full Text] [Related]

  • 19. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A, Markart P, Kalinowski M, Ruppert C, Grimminger F, Seeger W.
    Am J Respir Cell Mol Biol; 1999 Dec 01; 21(6):738-45. PubMed ID: 10572071
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.